Senzime expands into the French market driven by new clinical Guidelines
Press release: Uppsala, October 29, 2020. Senzime AB (publ) today announces that the company has entered into an exclusive agreement with The Surgical Company (formerly Sebac) for the French market, and the first order to a university hospital in France is ready to be delivered. Market entry is driven by the new clinical guidelines in France supporting the use of Senzime’s products in surgery. “France is one of the world's most important medical technology markets and thus an extremely important market in our commercial plan. The Surgical Company is a leader in the French